Study guide
12.1 Intangible Assets
AICPA CPA Exam — Financial Accounting & Reporting FAR
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Conceptual Framework and Standard Setting
1.1 Conceptual Framework 1.2 Standard Setting and GAAP vs. IFRS 1.3 Special Purpose Frameworks
2 Chapter 2: Financial Statement Presentation
2.1 Balance Sheet and Income Statement 2.2 Statement of Cash Flows 2.3 Retained Earnings and Comprehensive Income
3 Chapter 3: Disclosure and Analysis
3.1 Segment Reporting 3.2 Interim Reporting and Disclosures 3.3 Financial Statement Analysis and Ratios
4 Chapter 4: Accounting Changes and Corrections
4.1 Accounting Changes 4.2 Error Corrections 4.3 Subsequent Events
5 Chapter 5: SEC Reporting Requirements
5.1 SEC Forms and Regulations 5.2 SEC Filing Deadlines and Large Accelerated Filers 5.3 SEC Disclosures and MD&A
6 Chapter 6: State and Local Governmental Accounting Foundations
6.1 Governmental Accounting Principles 6.2 Fund Accounting 6.3 Budgetary Accounting
7 Chapter 7: Governmental and Not-for-Profit Reporting
7.1 GASB 34 Government-Wide Financial Statements 7.2 Not-for-Profit Financial Reporting 7.3 Not-for-Profit Special Accounting
8 Chapter 8: Cash and Receivables
8.1 Cash and Cash Equivalents 8.2 Accounts Receivable and CECL 8.3 Notes Receivable and Factoring
9 Chapter 9: Inventory Management
9.1 Inventory Valuation and Cost Flows 9.2 Lower of Cost or Market (LCM) and Lower of Cost or Net Realizable Value (LCNRV) 9.3 Retail Inventory Method and Gross Profit Estimation
10 Chapter 10: Property, Plant, and Equipment
10.1 Acquisition and Depreciation of PP&E 10.2 Impairment and Disposal of PP&E 10.3 Asset Retirement Obligations (ARO)
11 Chapter 11: Investments and Financial Instruments
11.1 Debt Investments 11.2 Equity Investments and Equity Method 11.3 Fair Value Option and Disclosures
12 Chapter 12: Intangibles and Goodwill
12.1 Intangible Assets 12.2 Goodwill Impairment 12.3 Research and Development and Software Costs
13 Chapter 13: Liabilities and Debt Financing
13.1 Current Liabilities and Accruals 13.2 Bonds Payable and Debt Issuance 13.3 Debt Extinguishment and Convertible Debt
14 Chapter 14: Stockholders' Equity and EPS
14.1 Stockholders' Equity and Treasury Stock 14.2 Dividends and Retained Earnings 14.3 Earnings Per Share (EPS)
15 Chapter 15: Revenue Recognition
15.1 The ASC 606 Five-Step Revenue Recognition Model 15.2 Allocation and Satisfaction of Performance Obligations 15.3 Special Revenue Recognition Scenarios
16 Chapter 16: Leases
16.1 Lessee Accounting 16.2 Lessor Accounting 16.3 Special Lease Transactions
17 Chapter 17: Business Combinations and Consolidations
17.1 Business Combinations 17.2 Consolidated Financial Statements 17.3 Noncontrolling Interest and Variable Interest Entities (VIEs)
18 Chapter 18: Income Taxes
18.1 Deferred Taxes and ASC 740 18.2 Valuation Allowances and NOLs 18.3 Unrecognized Tax Benefits
19 Chapter 19: Compensation and Benefits
19.1 Pension Plans 19.2 Stock-Based Compensation 19.3 Other Postretirement Benefits (OPEB)
20 Chapter 20: Specialized Financial Topics
20.1 Derivatives and Hedging 20.2 Foreign Currency Transactions and Translation 20.3 Nonmonetary Exchanges and Restructuring
12.1 Intangible Assets
Key Takeaways Explain This Topic AI
Externally acquired intangible assets are capitalized at acquisition cost, which includes purchase price, legal fees, and other direct costs.
Internally developed intangible assets are expensed as incurred (under R&D rules), except for direct costs like registration and successful legal defense fees.
Definite-life intangibles are amortized over the shorter of their useful or legal life, and tested for impairment under ASC 360 using a two-step recoverability test.
Indefinite-life intangibles are not amortized, but are tested for impairment annually (or more frequently if triggered) by directly comparing carrying value to fair value.
Reversals of impairment losses on intangible assets are strictly prohibited under US GAAP once recognized.
Last updated: July 2026
Intangible Assets: Capitalization, Amortization, and Impairment
Intangible assets are non-financial, non-monetary assets that lack physical substance but provide long-term economic value to an entity. Under US GAAP (specifically ASC 350 and ASC 360), these assets must be carefully classified and accounted for based on their acquisition source and the nature of their useful lives. This section breaks down the rules for capitalization, amortization, and the differing impairment testing models required for definite-life and indefinite-life intangible assets.
1. Capitalization vs. Expensing Rules
The accounting treatment for the initial recognition of an intangible asset depends entirely on whether the asset was purchased from an external party or developed internally.
Externally Acquired Intangible Assets
When an entity purchases an intangible asset from an external party, the transaction provides objective evidence of the asset's value. Therefore, US GAAP requires all externally acquired intangible assets to be capitalized at cost. The capitalized cost includes:
The purchase price paid to the seller.
Direct legal fees and registration costs incurred to secure the asset.
Any other costs directly attributable to preparing the asset for its intended use (such as testing or modifications).
If a group of assets is acquired in a single transaction, the cost is allocated to the individual assets based on their relative fair values. If the acquisition occurs as part of a business combination, the assets are recorded at their acquisition-date fair values.
Internally Developed Intangible Assets
In contrast, internally developed intangible assets face highly restrictive capitalization rules due to the lack of objective transaction-based valuation.
General Expensing Rule: Almost all costs incurred during the development of an internal intangible asset must be expensed as incurred. This includes salaries of employees working on the project, research costs, and prototype testing costs (which are categorized as Research and Development under ASC 730).
Capitalization Exceptions: An entity is permitted to capitalize only specific, direct costs incurred after the asset's technical feasibility is established and when the legal process begins. Capitalizable costs are limited to:
External legal fees incurred to register or successfully defend a patent or trademark.
Government and registration filing fees.
Document preparation and application costs.
If a legal defense of an intangible asset is unsuccessful , all associated legal fees must be expensed immediately, and the carrying value of the existing intangible asset must be written off as a loss, because the unsuccessful defense indicates the asset has no future economic value.
2. Amortization of Definite-Life Intangibles
Intangible assets are classified based on their useful lives. A "definite-life intangible asset" is one with a determinable period of utility (e.g., patents, copyrights, franchises with set terms, customer lists, and covenants not to compete).
Amortization Parameters
Amortization Period: Definite-life intangibles must be amortized over their estimated useful (economic) lives. However, the amortization period cannot exceed the asset's remaining legal life. For example, if a patent has a legal life of 20 years but is expected to be commercially obsolete in 8 years, it must be amortized over 8 years.
Amortization Method: The straight-line method is standard unless the entity can demonstrate that another systematic and rational method better reflects the pattern of economic consumption.
Residual Value: The residual value is assumed to be $0 unless:
A third party has committed to purchase the asset at the end of its useful life.
The residual value can be determined by reference to an active market that is expected to exist at the end of the asset's useful life.
- Amortization Journal Entry Debit: Amortization Expense $10,000
- Credit: Accumulated Amortization - Patent (or Patent directly) $10,000
- 3. Impairment of Definite-Life Intangibles (ASC 360)
Definite-life intangible assets are grouped with other long-lived assets (such as PP&E) for impairment testing. They are tested for impairment only when a triggering event occurs (e.g., a significant decrease in market price, a physical change in the asset, or an adverse change in legal factors or the business climate). The test is a two-step process:
Step 1: The Recoverability Test
Compare the carrying value of the asset to the sum of the undiscounted future cash flows expected to be generated by the asset's use and eventual disposal.
If Undiscounted Cash Flows >= Carrying Value: The asset is recoverable. No impairment is recognized.
If Undiscounted Cash Flows < Carrying Value: The carrying value is not recoverable. Proceed to Step 2.
Step 2: Measurement of the Impairment Loss
Calculate the impairment loss as the amount by which the carrying value exceeds the asset's fair value (which is typically measured using discounted cash flows or market inputs).
Impairment Loss = Carrying Value - Fair Value
Once an impairment loss is recognized, the reduced carrying value becomes the new cost basis. The asset's remaining useful life is reassessed, and amortization is adjusted prospectively. Reversals of impairment losses are strictly prohibited under US GAAP.
4. Impairment of Indefinite-Life Intangibles (ASC 350)
An "indefinite-life intangible asset" is one for which there is no foreseeable limit on the period over which the asset is expected to generate cash flows (e.g., trademarks, trade names, and broadcast licenses).
Amortization and Testing
Indefinite-life intangibles are never amortized . Instead, they must be tested for impairment at least annually , or more frequently if a triggering event occurs.
Testing Methodology
Qualitative Assessment (Optional Step 0): An entity can perform a qualitative assessment to determine if it is more likely than not (i.e., a probability > 50%) that the asset's fair value is less than its carrying value. If qualitative factors suggest no impairment, the quantitative test is bypassed. Otherwise, the entity must perform the quantitative test.
Quantitative Test: Compare the fair value of the asset directly to its carrying value.
If Fair Value >= Carrying Value: No impairment.
If Fair Value < Carrying Value: Impairment loss is recognized.
Impairment Loss = Carrying Value - Fair Value
Important
Because indefinite-life intangibles have no set useful life, their cash flows are projected to continue infinitely. Therefore, there is no undiscounted cash flow recoverability test (Step 1) for indefinite-life assets under US GAAP. Carrying value is compared directly to fair value.
5. Comparison: Definite-Life vs. Indefinite-Life Intangibles
- Accounting Feature Definite-Life Intangibles Indefinite-Life Intangibles
- Amortization Yes (Shorter of economic or legal life) No
- Testing Frequency Only when triggering events occur Annually (or more frequently if triggered)
- Qualitative Assessment Not applicable Yes (optional first step)
- Recoverability Test Yes (Step 1: Undiscounted cash flows) No (directly to fair value comparison)
- Measurement of Loss Carrying Value minus Fair Value Carrying Value minus Fair Value
- Impairment Reversal Prohibited Prohibited
- 6. Real-World Worked Examples
- Example 1: Definite-Life Patent Accounting
On January 1, 2026, Gamma Inc. purchased a patent from an inventor for $400,000 and paid $50,000 in legal fees to register the transfer. The patent has a remaining legal life of 12 years but is expected to be useful for only 10 years.
Initial Capitalization: Capitalize at cost of $400,000 + $50,000 = $450,000.
Annual Amortization: Amortize over 10 years (shorter of useful or legal life).
Annual Amortization = $450,000 / 10 = $45,000 per year
Impairment Assessment: On December 31, 2028 (after 3 years of amortization), the carrying value of the patent is:
Carrying Value = $450,000 - ($45,000 * 3) = $315,000
At this date, a competitor releases a superior product, triggering an impairment review. Gamma estimates the patent's undiscounted future cash flows will be $290,000, and its fair value (discounted cash flows) is $240,000.
Recoverability Test: Since Carrying Value ($315,000) exceeds Undiscounted Cash Flows ($290,000), the patent is impaired.
Measurement: Impairment Loss = Carrying Value ($315,000) - Fair Value ($240,000) = $75,000.
- Journal Entry: Debit: Loss on Impairment of Patent $75,000
- Credit: Accumulated Amortization - Patent $75,000
Subsequent Accounting: The new carrying value of $240,000 is amortized over the patent's remaining 7 years of useful life at $34,286 per year.
Example 2: Indefinite-Life Trademark Accounting
Delta Corp. has a registered trademark with a carrying value of $150,000 that is not amortized. On December 31, 2026, Delta performs its annual impairment test. Due to a decline in brand reputation, Delta estimates the trademark's fair value has dropped to $110,000.
Impairment Test: Because it is an indefinite-life asset, Delta bypasses the recoverability test and directly compares carrying value to fair value.
- Impairment Loss = $150,000 - $110,000 = $40,000
- * Journal Entry: Debit: Loss on Impairment of Trademark $40,000
Credit: Trademark $40,000 The trademark's carrying value is written down to $110,000. In 2027, if brand value recovers, no reversal of the $40,000 loss is permitted.